Use of Incretin-Based Drugs Does Not Increase the Risk of Cholangiocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
Diabetologia 2021 Oct 01;64(10)2204-2214, P Ueda, V Wintzell, M Melbye, B Eliasson, AM Svensson, S Franzén, S Gudbjörnsdottir, K Hveem, C Jonasson, H Svanström, B PasternakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.